Noncompaction cardiomyopathy left ventricular dysfunction
Noncompaction Cardiomyopathy Microchapters |
Pathophysiology |
---|
Differentiating Noncompaction Cardiomyopathy from other Diseases |
Diagnosis |
Treatment |
Noncompaction cardiomyopathy left ventricular dysfunction On the Web |
FDA on Noncompaction cardiomyopathy left ventricular dysfunction |
CDC on Noncompaction cardiomyopathy left ventricular dysfunction |
Noncompaction cardiomyopathy left ventricular dysfunction in the news |
Blogs on Noncompaction cardiomyopathy left ventricular dysfunction |
Risk calculators and risk factors for Noncompaction cardiomyopathy left ventricular dysfunction |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The phenotypic expression of NCC is variable, and two thirds of patients have left ventricular systolic and / or diastolic dysfunction[1]. Arrhythmias and embolization are also present.
Abnormalities in Cardiac Function
- There can be abnormalities in systolic and diastolic function. There can also be hypercontractile dysfunction.
- These patients are at risk of forming mural thrombus in the left ventricle and embolization. As a result, all patients with NCC are treated with prophylactic aspirin.
References
- ↑ Oechslin EN, Attenhofer Jost CH, Rojas JR, et al. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000; 36: 493–500.